Multidrug resistance in relapsed acute myeloid leukemia: evidence of biological heterogeneity.

Multidrug resistance in relapsed acute myeloid leukemia: evidence of biological heterogeneity.

Item
http://www.wikidata.org/entity/Q37076249
Rare Cytogenetic Abnormalities and Alteration of microRNAs in Acute Myeloid Leukemia and Response to TherapyProteomics-based discovery of biomarkers for paediatric acute lymphoblastic leukaemia: challenges and opportunitiesTracing dynamics and clonal heterogeneity of Cbx7-induced leukemic stem cells by cellular barcoding.The Role of Multidrug Resistance Efflux Pumps in Cancer: Revisiting a JNCI Publication Exploring Expression of the MDR1 (P-glycoprotein) Gene.ABCC4 Is a Determinant of Cytarabine-Induced Cytotoxicity and Myelosuppression.Personalized therapy for acute myeloid leukemia.The role of the dysfunctional akt-related pathway in cancer: establishment and maintenance of a malignant cell phenotype, resistance to therapy, and future strategies for drug development.Treatment of relapse of acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation.MRP1 protein expression in leukemic stem cells as a negative prognostic marker in acute myeloid leukemia patients.Molecular and genetic alterations associated with therapy resistance and relapse of acute myeloid leukemia.High-throughput profiling of signaling networks identifies mechanism-based combination therapy to eliminate microenvironmental resistance in acute myeloid leukemia.
P2860

Multidrug resistance in relapsed acute myeloid leukemia: evidence of biological heterogeneity.

Item
http://www.wikidata.org/entity/Q37076249
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 14 May 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Multidrug resistance in relaps ...... e of biological heterogeneity.
@en
Multidrug resistance in relaps ...... e of biological heterogeneity.
@nl
type
label
Multidrug resistance in relaps ...... e of biological heterogeneity.
@en
Multidrug resistance in relaps ...... e of biological heterogeneity.
@nl
prefLabel
Multidrug resistance in relaps ...... e of biological heterogeneity.
@en
Multidrug resistance in relaps ...... e of biological heterogeneity.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P698
P921
P932
P356
P1433
P1476
Multidrug resistance in relaps ...... e of biological heterogeneity.
@en
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P698
P921
P932